- Accesswire•2 days agoBlog Coverage Teva Reports Positive Outcome for the European Label for COPAXONE®; Replaces Generics Head
Upcoming AWS Coverage on Pernix Therapeutics Holdings Post-Earnings Results LONDON, UK / ACCESSWIRE / December 7, 2016 / Active Wall St. blog coverage looks at the headline from Teva Pharmaceutical Industries ...
- GlobeNewswire•17 days ago
MORRISTOWN, N.J., Nov. 22, 2016-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced the appointment of Gabriel Leung to its ...
- GlobeNewswire•28 days ago
Net Revenue Increased 13% Sequentially Over Second Quarter 2016. Prescription Volumes Grew Sequentially and Year-Over-Year for All Three Core Brands, Treximet ®, Zohydro ER ® with BeadTek™ and Silenor ...
PTX : Summary for Pernix Therapeutics Holdings, I - Yahoo Finance
Pernix Therapeutics Holdings, Inc. (PTX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||3.06 - 3.22|
|52 Week Range||0.39 - 4.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.13|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|